Royal Marsden NHS Foundation Trust
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH)
- Conditions
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 110
- Registration Number
- NCT00996450
- Locations
- π¬π§
The Royal Marsden NHS Foundation Trust, Belmont, Surrey, United Kingdom
Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency
- Conditions
- First Posted Date
- 2009-08-04
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 2
- Registration Number
- NCT00952016
- Locations
- π¬π§
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer
- Conditions
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 198
- Registration Number
- NCT00946543
- Locations
- π¬π§
Institute of Cancer Research - Chelsea, London, England, United Kingdom
π¬π§Royal Marsden - Surrey, Sutton, England, United Kingdom
π¬π§Institute of Cancer Research - Sutton, Sutton, England, United Kingdom
Functional Imaging in HNC Undergoing Chemoradiation
- Conditions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2009-02-06
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT00837980
- Locations
- π¬π§
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Measurement of the Folate Receptor in Blood
- Conditions
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 7
- Registration Number
- NCT00838747
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, London, Sutton, United Kingdom
REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-01-19
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 574
- Registration Number
- NCT00824785
- Locations
- π¬π§
Bournemouth, Bournemouth, United Kingdom
π¬π§Royal Liverpool, Liverpool, United Kingdom
π¬π§Newcastle, Newcastle, United Kingdom
SS-GCC1- Screening Study of Genetic Changes in Colorectal Cancer
- Conditions
- First Posted Date
- 2009-01-19
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 3750
- Registration Number
- NCT00825110
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 7
- Registration Number
- NCT00788606
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
π¬π§David Cunningham, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
FR in Stored Plasma
- Conditions
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 27
- Registration Number
- NCT00787514
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
- Conditions
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2008-09-09
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT00749697
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, London, Sutton, United Kingdom